[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344901-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344901-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","toward-timely-diagnosis-of-pancreatic-cancer-revolutionizing-early-detection-through-genomics-artificial-intelligence-and-noninvasive-biomarkers","Toward Timely Diagnosis of Pancreatic Cancer - Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers","","Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive and often detected at advanced stages because early symptoms are subtle or absent. With early diagnosis constrained by limited screening tools and persistently poor survival outcomes, the study reviews recent progress toward earlier detection. It focuses on novel biomarkers, liquid biopsy approaches, AI-enhanced imaging, and noninvasive surveillance in high-risk groups, including hereditary cancer syndromes. Emerging AI imaging and liquid biopsy show promise for identifying earlier, potentially resectable disease, while validation is still needed.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/toward-timely-diagnosis-of-pancreatic-cancer-revolutionizing-early-detection-through-genomics-artificial-intelligence-and-noninvasive-biomarkers/344901/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/toward-timely-diagnosis-of-pancreatic-cancer-revolutionizing-early-detection-through-genomics-artificial-intelligence-and-noninvasive-biomarkers/344901.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early diagnosis of pancreatic cancer difficult?","Question",{"text":63,"@type":64},"PDAC is often diagnosed at an advanced stage because early symptoms are subtle or absent. Effective screening tools are currently lacking, which limits early detection and worsens survival outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What methods does the review emphasize for improving detection?",{"text":68,"@type":64},"The review highlights novel biomarkers, liquid biopsies, circulating tumor DNA (ctDNA) and microRNAs, AI-enhanced imaging, and noninvasive surveillance strategies. It also considers advanced imaging modalities such as MRI, EUS, and MRCP in high-risk individuals.",{"name":70,"@type":61,"acceptedAnswer":71},"How do surveillance and AI contribute to earlier detection?",{"text":72,"@type":64},"Surveillance in high-risk populations (including BRCA1/2 mutation carriers and individuals with Lynch syndrome) has shown increased detection of stage I PDAC. AI and machine learning improve the sensitivity and specificity of imaging, supporting earlier-stage diagnosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344901,1790192599,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Journal of  \nGastroenterology and Hepatology  \nToward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers  \nMuhammad Masroor Hussain1,2  | Sana Qammar3 | Ju-Mei Wang1,2 | Ao-Qiang Zhai1,2 | Fu-yu Li1,2  | Hai-jie Hu1,2  \n1Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China | 2Research Center for Biliary  \nDiseases, West China Hospital, Sichuan University, Chengdu, China | 3Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan Correspondence: Fu-yu Li ([lfy_74@hotmail.com](lfy_74@hotmail.com)) | Hai-jie Hu ([haijiehu@scu.edu.cn](haijiehu@scu.edu.cn))  \nReceived: 25 September 2025 | Revised: 16 December 2025 | Accepted: 30 January 2026  \nKeywords: artificial intelligence | ctDNA | early detection | high-risk surveillance | liquid biopsy | miRNA | noninvasive biomarkers | pancreatic ductal adenocarcinoma | radiomics  \nABSTRACT  \nBackground: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive cancers, typically diagnosed at an advanced stage due to its subtle and often absent early symptoms. Despite representing only 3% of new cancer cases, it is projected to become the second leading cause of cancer-related deaths by 2030. Currently, early diagnosis remains a significant challenge, and survival rates remain poor due to the lack of effective screening tools.  \nMethods: We conducted a comprehensive literature review to explore the most recent advances in PDAC detection, focusing on novel biomarkers, liquid biopsies, artificial intelligence (AI)–enhanced imaging, and non-invasive surveillance strategies. We examined the role of circulating tumor DNA (ctDNA), microRNAs, and volatile organic compounds (VOCs) as diagnostic tools, alongside the integration of advanced imaging modalities like MRI, EUS, and MRCP in high-risk individuals, including those with hereditary cancer syndromes.  \nResults: Emerging technologies, such as AI-driven imaging and liquid biopsy, have shown promising improvements in detecting PDAC at earlier, potentially resectable stages. Surveillance strategies for high-risk populations, including BRCA1/2 mutation carriers and individuals with Lynch syndrome, have demonstrated increased detection of Stage I PDAC, offering a significant opportunity for curative intervention. AI and machine learning techniques are also enhancing the sensitivity and specificity of imaging, providing a new frontier in early-stage diagnosis.  \n\n| Abbreviations: AI, artificial intelligence; ATM, ataxia-telangiectasia mutated; AUC, area under the curve; BMP3, bone morphogenetic protein 3; BRCA, breast cancer gene; CA 19-9, carbohydrate antigen 19-9; CA125, cancer antigen 125; CA242, cancer antigen 242; CAPS, Cancer of the Pancreas Screening (program); CDKN2A, cyclin-dependent kinase inhibitor 2A; CEA, carcinoembryonic antigen; CEH-EUS, contrast-enhanced harmonic endoscopic ultrasound; cfDNA, cell-free DNA; CT, computed tomography; CTCs, circulating tumor cells; ctDNA, circulating tumor DNA; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; EUS-FNA, endoscopic ultrasound–fine-needle aspiration; FDA, Food and Drug Administration; FNA, fine-needle aspiration; GC-IMS, gas chromatography–ion mobility spectrometry; GC-TOF-MS, gas chromatography–time-of-flight mass spectrometry; IMS, ion mobility spectrometry; IPMN, intraductal papillary mucinous neoplasm; KRAS, Kirsten rat sarcoma viral oncogene homolog; LFTs, liver function tests; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; MicroRNA, miRNA/miR; MOB, methylation on beads; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging; MUC5AC, mucin 5AC; OS, overall survival; PAC model, pancreatic cancer prediction model; PALB2, partner and localizer ofBRCA2; PDAC, pancreatic ductaladenocarcinoma; PGV, pathogenic germline variant; PIK3CA, phosph","cbCairxA8p8QQbsi","https://ap.wps.com/l/cbCairxA8p8QQbsi","pdf",1067633,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion","[{\"question\":\"Why is early diagnosis of pancreatic cancer difficult?\",\"answer\":\"PDAC is often diagnosed at an advanced stage because early symptoms are subtle or absent. Effective screening tools are currently lacking, which limits early detection and worsens survival outcomes.\"},{\"question\":\"What methods does the review emphasize for improving detection?\",\"answer\":\"The review highlights novel biomarkers, liquid biopsies, circulating tumor DNA (ctDNA) and microRNAs, AI-enhanced imaging, and noninvasive surveillance strategies. It also considers advanced imaging modalities such as MRI, EUS, and MRCP in high-risk individuals.\"},{\"question\":\"How do surveillance and AI contribute to earlier detection?\",\"answer\":\"Surveillance in high-risk populations (including BRCA1/2 mutation carriers and individuals with Lynch syndrome) has shown increased detection of stage I PDAC. AI and machine learning improve the sensitivity and specificity of imaging, supporting earlier-stage diagnosis.\"}]","Toward Timely Diagnosis of Pancreatic Cancer - Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers | PDF",1790055697,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32696752fb82c81ad537411b56acfa74.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fb8fa1d8ee063b50427972c8403afbb.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f790007b86357c01ecc6b3b91d17b247.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67593ea9beb0eb7c008599750f70d97f.webp",980,1287]